Forbes October 28, 2024
Robert Pearl, M.D.

The American medical system has become undeniably complex, a far cry from the days when doctors made house calls and patients paid directly for care.

With the rise of advanced medical technologies, high-priced procedures and for-profit insurance, U.S. healthcare had—by the late-20th century—transformed into a sprawling and sophisticated industry. As hospitals expanded and insurance options multiplied, individuals and businesses quickly found themselves overwhelmed by the system.

To help manage the growing complexities, a new class of healthcare intermediaries emerged. These “middlemen of medicine” assisted providers, patients and employers with tasks like billing, selecting insurance plans and negotiating drug prices. At a time when healthcare was becoming increasingly convoluted, they offered valuable solutions.

But today, rather than evolving to meet modern...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Pharma, Pharma / Biotech, Provider
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights
Kura Oncology Gets $330M to Kick Off Global Leukemia Drug Pact With Kyowa Kirin

Share This Article